Investigational Drug Information for Taspoglutide
✉ Email this page to a colleague
What is the drug development status for Taspoglutide?
Taspoglutide is an investigational drug.
There have been 13 clinical trials for Taspoglutide.
The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2008.
The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and Cardiovascular Diseases. The leading clinical trial sponsors are Hoffmann-La Roche and [disabled in preview].
Summary for Taspoglutide
US Patents | 0 |
International Patents | 0 |
US Patent Applications | 1,089 |
WIPO Patent Applications | 897 |
Japanese Patent Applications | 614 |
Clinical Trial Progress | Phase 3 (2008-08-01) |
Vendors | 3 |
Recent Clinical Trials for Taspoglutide
Title | Sponsor | Phase |
---|---|---|
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease | Hoffmann-La Roche | Phase 3 |
A Study to Compare Taspoglutide and Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea Combination Therapy | Hoffmann-La Roche | Phase 3 |
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes | Hoffmann-La Roche | Phase 3 |
Clinical Trial Summary for Taspoglutide
Top disease conditions for Taspoglutide
Top clinical trial sponsors for Taspoglutide
US Patents for Taspoglutide
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |